Hi,
I really like your math. It more or less hits where I was guestimating, but I haven't actually done the math. I think $1.2 is pretty dead on, but could you possibly provide an estimated range instead? I'm guessing $1-1.5, without doing the math.
To the people panicking, young stocks are always volatile to short term manipulation. This is just a known fact. There's really no reason for the general negativity and attitudes. Everyone trade on the style that is comfortable for them. A short term trader would've made some good money off this stock in the past month as it rose and fell. However, it bears no effect on long term investors, who will profit base on the performance of the company.
The last time I posted, I've said that the Fluticare FDA approval is a bonus for this company and good reason for many of us to hold and wait. However, even without it, this company is already established and will continue to grow. So the reality of it is, if you are a long term investor and you're panicking b/c of these fluxuations in the short term prices, then your mentality is still a short term trader.
You have to ask yourself. Without the Fluticare FDA, would you still have invested in this stock on the long run? If your answer is yes, then you have to look at the company growth and the projected estimate without the FDA and see if it is still worth investing. The FDA is just a bonus.
Fact remains, even if you bought shares at the 0.6 peak, you would still profit considerably if the FDA is approved. If not, you just have to wait a little longer. It will break the $1 barrier, obviously, just a question of when.
Good luck, folks!
News 
Market Data 
Discover 
